check_circleStudy Completed
Prostate Cancer
Bayer Identifier:
14166
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Androcur Effects on Quality of Life
Trial purpose
Androcur is an antiandrogenic drug, which blocks the action of male sex hormones. Androcur is used for treatment of advanced prostate cancer. This study investigates the effect of Androcur on quality of life of prostate cancer patients who are taking the drug for 12 months
Key Participants Requirements
Sex
MaleAge
18 YearsTrial summary
Enrollment Goal
245Trial Dates
June 2008 - January 2010Phase
N/ACould I Receive a placebo
NoProducts
Androcur (Cyproterone Acetate, BAY94-8367)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Hungary |
Primary Outcome
- Quality of life change measured by SF-35 questionnairedate_rangeTime Frame:Baseline, after 3, 6 and 12 monthenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A